Corcept Therapeutics Incorporated
US ˙ NasdaqCM ˙ US2183521028

SecurityCORT / Corcept Therapeutics Incorporated
InstitutionIFP Advisors, Inc
Latest Disclosed Ownership136 shares
Latest Disclosed Value $ 5,482
IFP Advisors, Inc reports 27.66% decrease in ownership of CORT / Corcept Therapeutics Incorporated

On April 13, 2026 - IFP Advisors, Inc filed a 13F-HR form disclosing ownership of 136 shares of Corcept Therapeutics Incorporated (US:CORT) valued at $5,482 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 188 shares of Corcept Therapeutics Incorporated. This represents a change in shares of -27.66% during the quarter. The current value of the position is $9,880 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-13 2026-03-31 13F CORCEPT THERAPEUTICS cs 218352102 136 -52 -27.66 5 -16.67 0.0001
2026-02-06 2025-12-31 13F CORCEPT THERAPEUTICS cs 218352102 188 -154 -45.03 7 -78.57 0.0001
2026-02-06 2025-09-30 13F/A-1 CORCEPT THERAPEUTICS cs 218352102 342 -84 -19.72 28 -9.68 0.0007
2025-12-02 2025-09-30 13F CORCEPT THERAPEUTICS cs 218352102 342 -84 28 0.0007
2025-07-24 2025-06-30 13F CORCEPT THERAPEUTICS cs 218352102 426 -312 -42.28 31 -63.10 0.0009
2025-05-05 2025-03-31 13F CORCEPT THERAPEUTICS cs 218352102 738 679 1,150.85 84 4,100.00 0.0026
2025-02-04 2024-12-31 13F CORCEPT THERAPEUTICS cs 218352102 59 11 22.92 3 0.00 0.0001
2025-02-04 2024-09-30 13F CORCEPT THERAPEUTICS cs 218352102 48 0 0.00 2 100.00 0.0001
2024-07-30 2024-06-30 13F CORCEPT THERAPEUTICS cs 218352102 48 48 2 0.0001
2023-04-18 2023-03-31 13F CORCEPT THERAPEUTICS cs 218352102 0 -3,645 -100.00 0 0.0000
2023-02-07 2022-12-31 13F CORCEPT THERAPEUTICS cs 218352102 3,645 -125 -3.32 0 -100.00 0.0022
2022-11-08 2022-09-30 13F CORCEPT THERAPEUTICS cs 218352102 3,770 64 1.73 84 0.00 0.0022
2022-09-06 2022-06-30 13F/A-1 CORCEPT THERAPEUTICS cs 218352102 3,706 0 0.00 84 0.00 0.0027
2022-09-06 2022-03-31 13F/A-1 CORCEPT THERAPEUTICS cs 218352102 3,706 2,453 195.77 84 211.11 0.0027
2022-08-08 2022-03-31 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 1,278 25 26 0.0005
2022-01-12 2021-12-31 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 1,253 100 8.67 27 8.00 0.0005
2021-10-06 2021-09-30 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 1,153 997 639.10 25 525.00 0.0005
2021-07-13 2021-06-30 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 156 156 4 0.0001
2021-04-30 2021-03-31 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 0 0 0 0.0000
2021-01-25 2020-12-31 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 0 0 0 0.0000
2020-10-29 2020-09-30 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 0 0 0 0.0000
2020-08-05 2020-06-30 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 0 0 0 0.0000
2020-05-12 2020-03-31 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 0 0 0 0.0000
2020-01-17 2019-12-31 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 0 0 0 0.0000
2019-11-07 2019-09-30 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 0 0 0 0.0000
2019-05-15 2019-03-31 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 0 -275 -100.00 0 -100.00
2019-06-03 2018-12-31 13F/A-10 CORCEPT THERAPEUTICS INC COM Stock 218352102 275 -601 -68.61 4 -66.67 0.0002
2019-01-23 2018-12-31 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 275 -601 4 0.0002
2019-06-03 2018-09-30 13F/A-9 CORCEPT THERAPEUTICS INC COM Stock 218352102 876 554 172.05 12 140.00 0.0005
2018-10-25 2018-09-30 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 876 554 12 0.0005
2019-06-03 2018-06-30 13F/A-8 CORCEPT THERAPEUTICS INC COM Stock 218352102 322 0 0.00 5 0.00 0.0002
2018-08-07 2018-06-30 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 322 0 5
2018-05-09 2018-03-31 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 322 322 5 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.